Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 196

1.

Coronary Artery Features of Immunoglobulin-G4-Related Coronary Periarteritis With Multi-Modality Visualization.

Sudo M, Fukamachi D, Yoda S, Okumura Y.

Circ J. 2019 Oct 3. doi: 10.1253/circj.CJ-19-0477. [Epub ahead of print] No abstract available.

2.

A phase II trial of induction of erlotinib followed by cytotoxic chemotherapy for EGFR mutation-positive non-squamous non-small cell lung cancer patients.

Tani T, Naoki K, Yasuda H, Arai D, Ishioka K, Ohgino K, Yoda S, Nakayama S, Satomi R, Terai H, Ikemura S, Sato T, Soejima K.

Cancer Chemother Pharmacol. 2019 Nov;84(5):1065-1071. doi: 10.1007/s00280-019-03934-y. Epub 2019 Sep 6.

PMID:
31493177
3.

The new-generation selective ROS1/NTRK inhibitor DS-6051b overcomes crizotinib resistant ROS1-G2032R mutation in preclinical models.

Katayama R, Gong B, Togashi N, Miyamoto M, Kiga M, Iwasaki S, Kamai Y, Tominaga Y, Takeda Y, Kagoshima Y, Shimizu Y, Seto Y, Oh-Hara T, Koike S, Nakao N, Hanzawa H, Watanabe K, Yoda S, Yanagitani N, Hata AN, Shaw AT, Nishio M, Fujita N, Isoyama T.

Nat Commun. 2019 Aug 9;10(1):3604. doi: 10.1038/s41467-019-11496-z.

4.

Risk Stratification of Cardiovascular Events in Very Elderly Patients with Known or Suspected Coronary Artery Disease Who had Normal Single-photon Emission Computed Tomographic Myocardial Perfusion Imaging Findings.

Mineki T, Yoda S, Hatta T, Hayase M, Monno K, Hori Y, Suzuki Y, Matsumoto N, Okumura Y.

Intern Med. 2019 Jul 31. doi: 10.2169/internalmedicine.2843-19. [Epub ahead of print]

5.

The mimetic wing pattern of Papilio polytes butterflies is regulated by a doublesex-orchestrated gene network.

Iijima T, Yoda S, Fujiwara H.

Commun Biol. 2019 Jul 10;2:257. doi: 10.1038/s42003-019-0510-7. eCollection 2019.

6.

Usefulness of Dual-Phase Snapshot 320-Detector Computed Tomography for the Detection of a Left Atrial Appendage Thrombus.

Kuronuma K, Matsumoto N, Suzuki Y, Makita A, Ashida T, Yokoyama K, Yoda S, Okumura Y.

Int Heart J. 2019 Jul 27;60(4):849-853. doi: 10.1536/ihj.18-521. Epub 2019 Jul 12.

7.

Cardiovascular Outcomes in Patients With Previous Myocardial Infarction and Mild Diabetes Mellitus Following Treatment With Pioglitazone: Reports of a Randomised Trial From The Japan Working Group for the Assessment Whether Pioglitazone Protects DM Patients Against Re-Infarction (PPAR Study).

Asakura M, Kim J, Asanuma H, Nakama Y, Tsukahara K, Higashino Y, Ishikawa T, Koba S, Tsujimoto M, Himeno H, Maruyama Y, Ookusa T, Yoda S, Suzuki H, Okubo S, Shimizu M, Hashimoto Y, Satake K, Fujino S, Uzui H, Nagai Y, Kohno T, Mizuno S, Nakahama M, Kanaya H, Murohara T, Fukui K, Takase H, Ohte N, Shiono T, Fukunami M, Endo T, Sawada R, Fujii K, Takeuchi M, Ikeda S, Mizuno K, Uematsu M, Matsubara T, Yano S, Takahashi J, Ueda K, Kinoshita Y, Tamita K, Hayashi H, Hamasaki T, Kitakaze M; PPAR investigators.

EClinicalMedicine. 2018 Oct 22;4-5:10-24. doi: 10.1016/j.eclinm.2018.09.006. eCollection 2018 Oct-Nov.

8.

Clinical Impact of Coronary Computed Tomography Angiography-Derived Fractional Flow Reserve on Japanese Population in the ADVANCE Registry.

Shiono Y, Matsuo H, Kawasaki T, Amano T, Kitabata H, Kubo T, Morino Y, Yoda S, Sakamoto T, Ito H, Shite J, Otake H, Tanaka N, Terashima M, Kadota K, Patel MR, Nieman K, Rogers C, Nørgaard BL, Bax JJ, Raff GL, Chinnaiyan KM, Berman DS, Fairbairn TA, Hurwitz Koweek LM, Leipsic J, Akasaka T.

Circ J. 2019 May 24;83(6):1293-1301. doi: 10.1253/circj.CJ-18-1269. Epub 2019 Apr 18.

9.

Phase Behavior of a Carbon Dioxide/Methyl Trimethoxy Silane/Polystyrene Ternary System.

Matsukawa H, Yoda S, Okawa Y, Otake K.

Polymers (Basel). 2019 Feb 2;11(2). pii: E246. doi: 10.3390/polym11020246.

10.

Formation of Nanofibrous Structure in Biopolymer Aerogel during Supercritical CO2 Processing: The Case of Chitosan Aerogel.

Takeshita S, Sadeghpour A, Malfait WJ, Konishi A, Otake K, Yoda S.

Biomacromolecules. 2019 May 13;20(5):2051-2057. doi: 10.1021/acs.biomac.9b00246. Epub 2019 Apr 4.

PMID:
30908038
11.

Protrusion of a loop-shaped 0.035-inch wire without the fracture of the self-expanding nitinol stent: A case report and experimental study.

Karashima E, Kawasaki D, Yoda S, Yasuda S, Kaneko T.

Clin Case Rep. 2019 Jan 13;7(2):357-360. doi: 10.1002/ccr3.1988. eCollection 2019 Feb.

12.

Effect of epicardial fat and metabolic syndrome on reverse atrial remodeling after ablation for atrial fibrillation.

Monno K, Okumura Y, Saito Y, Aizawa Y, Nagashima K, Arai M, Watanabe R, Wakamatsu Y, Otsuka N, Yoda S, Hiro T, Watanabe I, Hirayama A.

J Arrhythm. 2018 Oct 13;34(6):607-616. doi: 10.1002/joa3.12124. eCollection 2018 Dec.

13.

First report of hepatobiliary Mycobacterium avium infection developing obstructive jaundice in a patient with neutralizing anti-interferon-gamma autoantibodies.

Namkoong H, Asakura T, Ishii M, Yoda S, Masaki K, Sakagami T, Iwasaki E, Yamagishi Y, Kanai T, Betsuyaku T, Hasegawa N.

New Microbes New Infect. 2018 Oct 19;27:4-6. doi: 10.1016/j.nmni.2018.10.001. eCollection 2019 Jan.

14.

ESTIMATION OF PATIENT LENS DOSE ASSOCIATED WITH C-ARM CONE-BEAM COMPUTED TOMOGRAPHY USAGE DURING INTERVENTIONAL NEURORADIOLOGY.

Kawauchi S, Chida K, Moritake T, Matsumaru Y, Hamada Y, Sakuma H, Yoda S, Sun L, Sato M, Tsuruta W.

Radiat Prot Dosimetry. 2019 Aug 1;184(2):138-147. doi: 10.1093/rpd/ncy188.

PMID:
30452704
15.

Influence of balloon temperature and time to pulmonary vein isolation on acute pulmonary vein reconnection and clinical outcomes after cryoballoon ablation of atrial fibrillation.

Watanabe R, Okumura Y, Nagashima K, Iso K, Takahashi K, Arai M, Wakamatsu Y, Kurokawa S, Ohkubo K, Nakai T, Yoda S, Watanabe I, Hirayama A, Sonoda K, Tosaka T.

J Arrhythm. 2018 Sep 3;34(5):511-519. doi: 10.1002/joa3.12108. eCollection 2018 Oct.

16.

Landscape of Acquired Resistance to Osimertinib in EGFR-Mutant NSCLC and Clinical Validation of Combined EGFR and RET Inhibition with Osimertinib and BLU-667 for Acquired RET Fusion.

Piotrowska Z, Isozaki H, Lennerz JK, Gainor JF, Lennes IT, Zhu VW, Marcoux N, Banwait MK, Digumarthy SR, Su W, Yoda S, Riley AK, Nangia V, Lin JJ, Nagy RJ, Lanman RB, Dias-Santagata D, Mino-Kenudson M, Iafrate AJ, Heist RS, Shaw AT, Evans EK, Clifford C, Ou SI, Wolf B, Hata AN, Sequist LV.

Cancer Discov. 2018 Dec;8(12):1529-1539. doi: 10.1158/2159-8290.CD-18-1022. Epub 2018 Sep 26.

PMID:
30257958
17.

Targeting oncogenic drivers in lung cancer: Recent progress, current challenges and future opportunities.

Yoda S, Dagogo-Jack I, Hata AN.

Pharmacol Ther. 2019 Jan;193:20-30. doi: 10.1016/j.pharmthera.2018.08.007. Epub 2018 Aug 16. Review.

PMID:
30121320
18.

Prognostic impact of reducing myocardial ischemia identified using ECG-gated myocardial perfusion SPECT in Japanese patients with coronary artery disease: J-ACCESS 4 study.

Nanasato M, Matsumoto N, Nakajima K, Chikamori T, Moroi M, Takehana K, Momose M, Nishina H, Kasai T, Yoda S, Kiso K, Yamamoto H, Nishimura S, Yamashina A, Kusuoka H, Hirayama A, Nishimura T.

Int J Cardiol. 2018 Sep 15;267:202-207. doi: 10.1016/j.ijcard.2018.05.090. Epub 2018 May 24.

19.

Sequential ALK Inhibitors Can Select for Lorlatinib-Resistant Compound ALK Mutations in ALK-Positive Lung Cancer.

Yoda S, Lin JJ, Lawrence MS, Burke BJ, Friboulet L, Langenbucher A, Dardaei L, Prutisto-Chang K, Dagogo-Jack I, Timofeevski S, Hubbeling H, Gainor JF, Ferris LA, Riley AK, Kattermann KE, Timonina D, Heist RS, Iafrate AJ, Benes CH, Lennerz JK, Mino-Kenudson M, Engelman JA, Johnson TW, Hata AN, Shaw AT.

Cancer Discov. 2018 Jun;8(6):714-729. doi: 10.1158/2159-8290.CD-17-1256. Epub 2018 Apr 12.

20.

SHP2 inhibition restores sensitivity in ALK-rearranged non-small-cell lung cancer resistant to ALK inhibitors.

Dardaei L, Wang HQ, Singh M, Fordjour P, Shaw KX, Yoda S, Kerr G, Yu K, Liang J, Cao Y, Chen Y, Lawrence MS, Langenbucher A, Gainor JF, Friboulet L, Dagogo-Jack I, Myers DT, Labrot E, Ruddy D, Parks M, Lee D, DiCecca RH, Moody S, Hao H, Mohseni M, LaMarche M, Williams J, Hoffmaster K, Caponigro G, Shaw AT, Hata AN, Benes CH, Li F, Engelman JA.

Nat Med. 2018 May;24(4):512-517. doi: 10.1038/nm.4497. Epub 2018 Mar 5.

21.

Tracking the Evolution of Resistance to ALK Tyrosine Kinase Inhibitors through Longitudinal Analysis of Circulating Tumor DNA.

Dagogo-Jack I, Brannon AR, Ferris LA, Campbell CD, Lin JJ, Schultz KR, Ackil J, Stevens S, Dardaei L, Yoda S, Hubbeling H, Digumarthy SR, Riester M, Hata AN, Sequist LV, Lennes IT, Iafrate AJ, Heist RS, Azzoli CG, Farago AF, Engelman JA, Lennerz JK, Benes CH, Leary RJ, Shaw AT, Gainor JF.

JCO Precis Oncol. 2018;2018. doi: 10.1200/PO.17.00160. Epub 2018 Jan 23.

22.

Impact of EML4-ALK Variant on Resistance Mechanisms and Clinical Outcomes in ALK-Positive Lung Cancer.

Lin JJ, Zhu VW, Yoda S, Yeap BY, Schrock AB, Dagogo-Jack I, Jessop NA, Jiang GY, Le LP, Gowen K, Stephens PJ, Ross JS, Ali SM, Miller VA, Johnson ML, Lovly CM, Hata AN, Gainor JF, Iafrate AJ, Shaw AT, Ou SI.

J Clin Oncol. 2018 Apr 20;36(12):1199-1206. doi: 10.1200/JCO.2017.76.2294. Epub 2018 Jan 26.

23.

Patterns of Metastatic Spread and Mechanisms of Resistance to Crizotinib in ROS1-Positive Non-Small-Cell Lung Cancer.

Gainor JF, Tseng D, Yoda S, Dagogo-Jack I, Friboulet L, Lin JJ, Hubbeling HG, Dardaei L, Farago AF, Schultz KR, Ferris LA, Piotrowska Z, Hardwick J, Huang D, Mino-Kenudson M, Iafrate AJ, Hata AN, Yeap BY, Shaw AT.

JCO Precis Oncol. 2017;2017. doi: 10.1200/PO.17.00063. Epub 2017 Aug 16.

24.

Effect of Aggressive lipid-lowering treatment with Rosuvastatin on vascular endoTHelium function: evaluation of vascular endothelium function (EARTH study).

Takayama T, Hiro T, Yoda S, Fukamachi D, Haruta H, Kogo T, Mineki T, Murata H, Oshima T, Hirayama A.

Heart Vessels. 2018 Jun;33(6):590-594. doi: 10.1007/s00380-017-1094-0. Epub 2017 Dec 5.

PMID:
29209775
25.

Translucent, hydrophobic, and mechanically tough aerogels constructed from trimethylsilylated chitosan nanofibers.

Takeshita S, Yoda S.

Nanoscale. 2017 Aug 31;9(34):12311-12315. doi: 10.1039/c7nr04051b.

PMID:
28825069
26.

Does Treatment of Impaired Glucose Tolerance Improve Cardiovascular Outcomes in Patients with Previous Myocardial Infarction?

Asakura M, Kim J, Asanuma H, Hamasaki T, Tsukahara K, Higashino Y, Ishikawa T, Nakama Y, Koba S, Maruyama Y, Tsujimoto M, Himeno H, Ohkusa T, Fujino S, Shimizu M, Endo T, Yoda S, Muroya T, Murohara T, Ohte N, Suzuki H, Kohno T, Fukui K, Shiono T, Takase H, Uzui H, Nagai Y, Hashimoto Y, Ikeda S, Mizuno S, Tamita K, Fujita M, Satake K, Kinoshita Y, Nunohiro T, Sakagami S, Higaki J, Morii I, Sawada R, Hiasa Y, Shigemasa T, Nakahama M, Sata M, Doi O, Ueda T, Yamada T, Yamanouchi T, Yamaguchi H, Morita Y, Hayashi H, Kitakaze M; ABC investigators.

Cardiovasc Drugs Ther. 2017 Aug;31(4):401-411. doi: 10.1007/s10557-017-6740-3.

PMID:
28779371
27.

Correlation between early revascularization and major cardiac events demonstrated by ischemic myocardium in Japanese patients with stable coronary artery disease.

Yoda S, Hori Y, Hayase M, Mineki T, Hatta T, Suzuki Y, Matsumoto N, Hirayama A.

J Cardiol. 2018 Jan;71(1):44-51. doi: 10.1016/j.jjcc.2017.05.008. Epub 2017 Jul 18.

28.

Toll ligand Spätzle3 controls melanization in the stripe pattern formation in caterpillars.

KonDo Y, Yoda S, Mizoguchi T, Ando T, Yamaguchi J, Yamamoto K, Banno Y, Fujiwara H.

Proc Natl Acad Sci U S A. 2017 Aug 1;114(31):8336-8341. doi: 10.1073/pnas.1707896114. Epub 2017 Jul 17. Erratum in: Proc Natl Acad Sci U S A. 2017 Sep 5;:.

29.

Aldehyde Approach to Hydrophobic Modification of Chitosan Aerogels.

Takeshita S, Konishi A, Takebayashi Y, Yoda S, Otake K.

Biomacromolecules. 2017 Jul 10;18(7):2172-2178. doi: 10.1021/acs.biomac.7b00562. Epub 2017 Jun 28.

PMID:
28657715
30.

Egg white hydrolysate inhibits oxidation in mayonnaise and a model system.

Kobayashi H, Sasahara R, Yoda S, Kotake-Nara E.

Biosci Biotechnol Biochem. 2017 Jun;81(6):1206-1215. doi: 10.1080/09168451.2017.1290519. Epub 2017 Feb 16.

PMID:
28485214
31.

Erlotinib as second- or third-line treatment in elderly patients with advanced non-small cell lung cancer: Keio Lung Oncology Group Study 001 (KLOG001).

Miyawaki M, Naoki K, Yoda S, Nakayama S, Satomi R, Sato T, Ikemura S, Ohgino K, Ishioka K, Arai D, Namkoong H, Otsuka K, Miyazaki M, Tani T, Kuroda A, Nishino M, Yasuda H, Kawada I, Koh H, Nakamura M, Terashima T, Sakamaki F, Sayama K, Betsuyaku T, Soejima K.

Mol Clin Oncol. 2017 Mar;6(3):409-414. doi: 10.3892/mco.2017.1154. Epub 2017 Feb 6.

32.

Intra-arterial Contrasted Cone-beam Computed Tomography Assessment of Vessels Distal from Occluded Site in Acute Ischemic Stroke with Major Vessel Occlusion.

Amano T, Sato M, Matsumaru Y, Sakuma H, Yoda S, Hamada Y.

Neurol Med Chir (Tokyo). 2017 Jun 15;57(6):292-298. doi: 10.2176/nmc.tn.2016-0291. Epub 2017 Apr 26.

33.

Prognostic study of cardiac events in Japanese patients with chronic kidney disease using ECG-gated myocardial Perfusion imaging: Final 3-year report of the J-ACCESS 3 study.

Nakamura S, Kawano Y, Nakajima K, Hase H, Joki N, Hatta T, Nishimura S, Moroi M, Nakagawa S, Kasai T, Kusuoka H, Takeishi Y, Momose M, Takehana K, Nanasato M, Yoda S, Nishina H, Matsumoto N, Nishimura T.

J Nucl Cardiol. 2019 Apr;26(2):431-440. doi: 10.1007/s12350-017-0880-5. Epub 2017 Apr 24.

34.

High-voltage zones within the pulmonary vein antra: Major determinants of acute pulmonary vein reconnections after atrial fibrillation ablation.

Nagashima K, Watanabe I, Okumura Y, Iso K, Takahashi K, Watanabe R, Arai M, Kurokawa S, Nakai T, Ohkubo K, Yoda S, Hirayama A.

J Interv Card Electrophysiol. 2017 Aug;49(2):137-145. doi: 10.1007/s10840-017-0252-8. Epub 2017 Apr 21.

PMID:
28432503
35.

Ventricular Tachycardia as a Complication of Ledipasvir and Sofosbuvir Treatment for HCV Infection.

Nirei K, Nakamura H, Matsuoka S, Yamana Y, Yoda S, Hirayama A, Moriyama M.

Intern Med. 2017;56(7):787-790. doi: 10.2169/internalmedicine.56.7948. Epub 2017 Apr 1.

36.

Depiction of the discrepancy between fatty-acid metabolism and myocardial perfusion in takotsubo cardiomyopathy using dedicated cardiac semiconductor gamma camera.

Iida K, Matsumoto N, Makita A, Suzuki Y, Yoda S, Hirayama A.

Int J Cardiol. 2016 Nov 15;223:161-162. doi: 10.1016/j.ijcard.2016.08.165. Epub 2016 Aug 9. No abstract available.

PMID:
27537748
37.

Molecular Mechanisms of Resistance to First- and Second-Generation ALK Inhibitors in ALK-Rearranged Lung Cancer.

Gainor JF, Dardaei L, Yoda S, Friboulet L, Leshchiner I, Katayama R, Dagogo-Jack I, Gadgeel S, Schultz K, Singh M, Chin E, Parks M, Lee D, DiCecca RH, Lockerman E, Huynh T, Logan J, Ritterhouse LL, Le LP, Muniappan A, Digumarthy S, Channick C, Keyes C, Getz G, Dias-Santagata D, Heist RS, Lennerz J, Sequist LV, Benes CH, Iafrate AJ, Mino-Kenudson M, Engelman JA, Shaw AT.

Cancer Discov. 2016 Oct;6(10):1118-1133. Epub 2016 Jul 18.

38.

Prognostic Value of Major Cardiac Event Risk Score Estimated With Gated Myocardial Perfusion Imaging in Japanese Patients With Coronary Artery Disease.

Yoda S, Nakanishi K, Tano A, Hori Y, Hayase M, Mineki T, Suzuki Y, Matsumoto N, Hirayama A.

Int Heart J. 2016 Jul 27;57(4):408-16. doi: 10.1536/ihj.15-428. Epub 2016 Jun 29.

39.

Development of Human-Like Advanced Coronary Plaques in Low-Density Lipoprotein Receptor Knockout Pigs and Justification for Statin Treatment Before Formation of Atherosclerotic Plaques.

Li Y, Fuchimoto D, Sudo M, Haruta H, Lin QF, Takayama T, Morita S, Nochi T, Suzuki S, Sembon S, Nakai M, Kojima M, Iwamoto M, Hashimoto M, Yoda S, Kunimoto S, Hiro T, Matsumoto T, Mitsumata M, Sugitani M, Saito S, Hirayama A, Onishi A.

J Am Heart Assoc. 2016 Apr 18;5(4):e002779. doi: 10.1161/JAHA.115.002779.

40.

Intraluminal superior vena cava metastasis from adenosquamous carcinoma of the duodenum: A case report.

Takayoshi K, Ariyama H, Tamura S, Yoda S, Arita T, Yamaguchi T, Ozono K, Yamamoto H, Inadomi K, Kumagai H, Tanaka M, Okumura Y, Sagara K, Nio K, Nakano M, Arita S, Kusaba H, Odashiro K, Oda Y, Akashi K, Baba E.

Oncol Lett. 2016 Jan;11(1):605-609. Epub 2015 Nov 18.

41.

Clinical Feasibility of Simultaneous Acquisition Rest (99m)Tc/Stress (201)Tl Dual-Isotope Myocardial Perfusion Single-Photon Emission Computed Tomography With Semiconductor Camera.

Makita A, Matsumoto N, Suzuki Y, Hori Y, Kuronuma K, Yoda S, Kasama S, Iguchi N, Suzuki Y, Hirayama A.

Circ J. 2016;80(3):689-95. doi: 10.1253/circj.CJ-15-1077. Epub 2016 Jan 18.

42.

Improvements in Augmentation Index and Urinary Albumin Excretion With Benidipine in Hypertensive Patients With Chronic Kidney Disease.

Takayama T, Yoda S, Yajima Y, Kasamaki Y, Kunimoto S, Kanai T, Hirayama A.

Int Heart J. 2016;57(1):53-60. doi: 10.1536/ihj.15-208. Epub 2016 Jan 6.

43.

Aerodynamic levitator for large-sized glassy material production.

Yoda S, Cho WS, Imai R.

Rev Sci Instrum. 2015 Sep;86(9):093906. doi: 10.1063/1.4930008.

PMID:
26429456
44.

Endoscopic Transseptal Approach to Frontal Sinus Disease.

Nishiike S, Yoda S, Shikina T, Murata J.

Indian J Otolaryngol Head Neck Surg. 2015 Sep;67(3):287-91. doi: 10.1007/s12070-015-0879-7. Epub 2015 Jun 29.

45.

[Estimation of Maximum Entrance Skin Dose during Cerebral Angiography].

Kawauchi S, Moritake T, Hayakawa M, Hamada Y, Sakuma H, Yoda S, Satoh M, Sun L, Koguchi Y, Akahane K, Chida K, Matsumaru Y.

Nihon Hoshasen Gijutsu Gakkai Zasshi. 2015 Sep;71(9):746-57. doi: 10.6009/jjrt.2015_JSRT_71.9.746. Japanese.

46.

Major cardiac event risk scores estimated with gated myocardial perfusion imaging in Japanese patients with coronary artery disease.

Yoda S, Nakanishi K, Tano A, Hori Y, Suzuki Y, Matsumoto N, Hirayama A.

J Cardiol. 2016 Jan;67(1):64-70. doi: 10.1016/j.jjcc.2015.04.008. Epub 2015 May 14.

47.

Unexpected massive hemorrhage following the removal of a pleural drainage tube.

Seki M, Yoda S.

Intern Med. 2015;54(8):953-4. doi: 10.2169/internalmedicine.54.3719. Epub 2015 Apr 15.

48.

Significance of worsening renal function and nuclear cardiology for predicting cardiac death in patients with known or suspected coronary artery disease.

Yoda S, Nakanishi K, Tano A, Hori Y, Suzuki Y, Matsumoto N, Hirayama A.

J Cardiol. 2015 Nov;66(5):423-9. doi: 10.1016/j.jjcc.2015.01.003. Epub 2015 Feb 18.

49.

A Phase II study of S-1 and irinotecan combination therapy in previously treated patients with advanced non-small cell lung cancer.

Ikemura S, Naoki K, Yasuda H, Kawada I, Yoda S, Terai H, Sato T, Ishioka K, Arai D, Ohgino K, Kamata H, Miyata J, Kabata H, Betsuyaku T, Soejima K.

Jpn J Clin Oncol. 2015 Apr;45(4):356-61. doi: 10.1093/jjco/hyu226. Epub 2015 Jan 22.

PMID:
25612761
50.

A phase II study of biweekly paclitaxel and carboplatin in elderly patients with advanced non-small cell lung cancer.

Soejima K, Naoki K, Ishioka K, Nakamura M, Nakatani M, Kawada I, Watanabe H, Nakachi I, Yasuda H, Satomi R, Nakayama S, Yoda S, Ikemura S, Terai H, Sato T, Ohgino K, Arai D, Tani T, Kuroda A, Nishino M, Betsuyaku T.

Cancer Chemother Pharmacol. 2015 Mar;75(3):513-9. doi: 10.1007/s00280-014-2673-8. Epub 2015 Jan 7.

PMID:
25563719

Supplemental Content

Support Center